John (Tianqiang) Lu is currently the Head of Rare Diseases at Chiesi in China, bringing extensive experience in the pharmaceutical industry, particularly in rare disease and market access strategies. Previously, they held various roles at The Janssen Pharmaceutical Companies and Biogen, focusing on market access and value strategies. John has a Master of Business Administration from the University of North Carolina at Chapel Hill and a Bachelor's Degree in Accounting from Shanghai International Studies University. Their leadership skills were demonstrated as President of the After Five Bell Tower Toastmaster Club, where they significantly expanded membership.
This person is not in the org chart
This person is not in any teams
This person is not in any offices